- Sotera Health press release ( NASDAQ: SHC ): Q4 Non-GAAP EPS of $0.25 beats by $0.03 .
- Revenue of $252M (+4.6% Y/Y) beats by $4.54M .
-
Today, Sotera Health is providing its full-year 2023 outlook:
- Net revenues in the range of $1.055 to $1.090 billion, representing growth of approximately 5% to 9%, compared to the prior year vs. $1.08B consensus
- Adjusted EBITDA in the range of $530 to $550 million, representing growth of approximately 5% to 9%, compared to the prior year,
- Tax rate applicable to Adjusted Net Income in the range of 30% to 33%,
- Adjusted EPS in the range of $0.78 to $0.86 vs. $1.01 consensus, representing decline of 10% to 19% versus the prior year, primarily driven by increased interest expense and an increased tax rate,
- A fully diluted share count in the range of 283 to 285 million shares on a weighted-average basis,
- Capital expenditures in the range of $185 to $215 million, and
- 2023 year-end Net Leverage Ratio to be within the long-term stated range of 2.0x - 4.0x.
For further details see:
Sotera Health Non-GAAP EPS of $0.25 beats by $0.03, revenue of $252M beats by $4.54M